Farringdon Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
1,071
-1,867
-64% -$435K 0.13% 111
2026
Q1
$718K Buy
+2,938
New +$684K 0.16% 174
2025
Q3
Sell
-3,738
Closed -$571K 563
2025
Q2
$571K Sell
3,738
-3,503
-48% -$538K 0.19% 163
2025
Q1
$1.2M Buy
+7,241
New +$1.13M 0.61% 27

Other funds holding JNJ

Farringdon Capital's JNJ Position: Q2 2026 in Review

Farringdon Capital reduced its Johnson & Johnson (JNJ) stake by 64% in Q2 2026, selling an estimated $435K and leaving 1,071 shares worth $272K. The position accounts for 0.13% of the portfolio, ranked #111.

Farringdon Capital first reported a position in JNJ in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.2M in Q1 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Farringdon Capital held 1,071 shares of Johnson & Johnson worth $272K as of Q2 2026.
  • Farringdon Capital sold 1,867 Johnson & Johnson shares in Q2 2026, an estimated $435K.
  • Johnson & Johnson made up 0.13% of Farringdon Capital's portfolio in Q2 2026, its #111 holding.
  • Farringdon Capital first reported a position in Johnson & Johnson in Q1 2025 and has held it in 4 quarters since.
  • Farringdon Capital's Johnson & Johnson position peaked at $1.2M in Q1 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.